Suppr超能文献

欧洲“关爱宪法性错配修复缺陷患者”联盟(C4CMMR-D)提出的宪法性错配修复缺陷个体监测指南。

Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium "Care for CMMR-D" (C4CMMR-D).

作者信息

Vasen H F A, Ghorbanoghli Z, Bourdeaut F, Cabaret O, Caron O, Duval A, Entz-Werle N, Goldberg Y, Ilencikova D, Kratz C P, Lavoine N, Loeffen J, Menko F H, Muleris M, Sebille G, Colas C, Burkhardt B, Brugieres L, Wimmer K

机构信息

Department of Gastroenterology & Hepatology, Leiden University Medical Centre, Leiden, The Netherlands.

出版信息

J Med Genet. 2014 May;51(5):283-93. doi: 10.1136/jmedgenet-2013-102238. Epub 2014 Feb 20.

Abstract

Lynch syndrome (LS) is an autosomal dominant disorder caused by a defect in one of the DNA mismatch repair genes: MLH1, MSH2, MSH6 and PMS2. In the last 15 years, an increasing number of patients have been described with biallelic mismatch repair gene mutations causing a syndrome referred to as 'constitutional mismatch repair-deficiency' (CMMR-D). The spectrum of cancers observed in this syndrome differs from that found in LS, as about half develop brain tumours, around half develop digestive tract cancers and a third develop haematological malignancies. Brain tumours and haematological malignancies are mainly diagnosed in the first decade of life, and colorectal cancer (CRC) and small bowel cancer in the second and third decades of life. Surveillance for CRC in patients with LS is very effective. Therefore, an important question is whether surveillance for the most common CMMR-D-associated cancers will also be effective. Recently, a new European consortium was established with the aim of improving care for patients with CMMR-D. At a workshop of this group held in Paris in June 2013, one of the issues addressed was the development of surveillance guidelines. In 1968, criteria were proposed by WHO that should be met prior to the implementation of screening programmes. These criteria were used to assess surveillance in CMMR-D. The evaluation showed that surveillance for CRC is the only part of the programme that largely complies with the WHO criteria. The values of all other suggested screening protocols are unknown. In particular, it is questionable whether surveillance for haematological malignancies improves the already favourable outcome for patients with these tumours. Based on the available knowledge and the discussions at the workshop, the European consortium proposed a surveillance protocol. Prospective collection of all results of the surveillance is needed to evaluate the effectiveness of the programme.

摘要

林奇综合征(LS)是一种常染色体显性疾病,由DNA错配修复基因之一(MLH1、MSH2、MSH6和PMS2)的缺陷引起。在过去15年中,越来越多双等位基因错配修复基因突变导致的患者被描述为患有“遗传性错配修复缺陷”(CMMR-D)综合征。该综合征中观察到的癌症谱与林奇综合征不同,约一半患者会发生脑肿瘤,约一半会发生消化道癌症,三分之一会发生血液系统恶性肿瘤。脑肿瘤和血液系统恶性肿瘤主要在生命的第一个十年被诊断出来,而结直肠癌(CRC)和小肠癌则在生命的第二个和第三个十年被诊断出来。对林奇综合征患者进行结直肠癌监测非常有效。因此,一个重要的问题是,对最常见的与CMMR-D相关的癌症进行监测是否也会有效。最近,一个新的欧洲联盟成立,旨在改善对CMMR-D患者的护理。在2013年6月于巴黎举行的该小组研讨会上,讨论的问题之一是制定监测指南。1968年,世界卫生组织提出了实施筛查计划之前应满足的标准。这些标准被用于评估CMMR-D中的监测。评估表明,结直肠癌监测是该计划中唯一基本符合世界卫生组织标准的部分。所有其他建议的筛查方案的价值尚不清楚。特别是,对血液系统恶性肿瘤的监测是否能改善这些肿瘤患者本已良好的预后值得怀疑。基于现有知识和研讨会上的讨论,欧洲联盟提出了一项监测方案。需要前瞻性收集监测的所有结果,以评估该方案的有效性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验